Bioventure is investing in Repairon – a spin-off from the University Medical Center Göttingen (UMG) – with the aim of supporting the clinical development and commercialization of its pioneering "heart patch" therapy.
Read moreBioventure is investing in Repairon – a spin-off from the University Medical Center Göttingen (UMG) – with the aim of supporting the clinical development and commercialization of its pioneering "heart patch" therapy.
Read moreDonation from Bioventure to the Federal Association for Children with Heart Disease (BVHK)
Read moreThe visit focused on discussions about the future of the life science sector in Göttingen and potential cooperation opportunities for investors in biotechnology and medical technology.
Read more